Telix Pharmaceuticals (TLX) Debt to Equity (2000 - 2025)
Telix Pharmaceuticals (TLX) debt to equity from Sep 30, 2000 to Dec 31, 2025. The current Telix Pharmaceuticals (TLX) debt to equity is 126.07%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Telix Pharmaceuticals (TLX)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 126.07% | +23.20% |
| 2024 | 102.33% | +773.24% |
| 2023 | 11.72% | -10.28% |
| 2022 | 13.06% | -88.89% |
| 2021 | 117.59% | +4104.60% |
| 2020 | 2.80% | -7.98% |
| 2019 | 3.04% | -7.06% |
| 2018 | 3.27% | +360.55% |
| 2017 | 0.71% | -100.30% |
| 2016 | -238.42% | -71.71% |
| 2015 | -842.86% | +334.44% |
| 2014 | -194.01% | -201.05% |
| 2013 | 192.00% | -550.89% |
| 2011 | -42.58% | N/A |
| 2000 | 0.00% | N/A |
Comparison Telix Pharmaceuticals (TLX) debt to equity with competitors
Telix Pharmaceuticals (TLX) debt to equity is 126.07%.